tirzepatide cardiovascular outcomes study trial results july 2025 Achieving BMI <25 kg/m2 was associated with reduced tirzepatide cardiovascular outcomes trial 2024

No, theyre not as powerful as a GLP-1 medication

Heres what you can expect from working with Paloma Health: Comprehensive thyroid care , including convenient home thyroid testing, symptom tracking, and personalized treatment plans Metabolic health assessments to determine GLP-1 suitability and guide next steps Integrated, whole-body care that aligns your thyroid treatment with your weight loss and blood sugar goals Ongoing support and education , so you never feel like youre navigating your health alone Individualized care, consistent monitoring, and a deep understanding of how thyroid and metabolic systems interact are the foundation of our approach

Many people at stable maintenance doses report minimal or no side effects after the initial adjustment period

Conversely, patients with mild insulin resistance but strong hunger signals may notice satiety effects within 7-10 days of starting injection formulations

Both medications use a gradual dose escalation schedule specifically to minimize early side effects